NuVasive acquires Simplify Medical 

3673

NuVasive has acquired Simplify Medical, a privately-held company and developer of the Simplify Cervical Artificial Disc (Simplify Disc) for cervical total disc replacement (cTDR).

According to a company press release, with this acquisition NuVasive is now able to address all key segments of the cervical spine by offering comprehensive, procedurally integrated solutions across anterior cervical discectomy and fusion (ACDF), posterior cervical fusion (PCF), and cTDR procedures.

“The acquisition of Simplify Medical advances our previously communicated long-term growth strategy by both expanding, and further distinguishing, our portfolio with industry-leading innovation,” said J Christopher Barry, chief executive officer of NuVasive. “Combining the Simplify Disc with NuVasive’s C360 portfolio will enable us to provide surgeons with world-class cervical technology, regardless of their preferred procedural approach. We are excited about the opportunities this acquisition creates as we work to optimise the surgeon experience, advance the standard of care, and create value for shareholders.”

According to NuVasive, the Simplify Disc is supported by level-1 evidence through the FDA investigational device exemption (IDE) study and was found to be clinically superior to ACDF in the randomised controlled trial. The device is currently being evaluated in a separate IDE study in the US for 2-level indications, pending FDA approval.

“As demonstrated by the strong clinical data and the unique design characteristics of the Simplify Disc, we share NuVasive’s focus on outcome-driven innovation,” said David Hovda, president and chief executive officer of Simplify Medical. “Together, we create a comprehensive, procedurally integrated cervical portfolio differentiated by technology and breadth. NuVasive’s scale and global commercial channels will greatly accelerate the ability to bring the Simplify Disc to more surgeons and patients around the world.”

According to the company, Simplify Medical’s technology was designed to offer surgeons best-in-class capabilities for cTDR across key performance functions, including:

  • Radiologic Design: The disc, uniquely comprised of polyether ether ketone (PEEK) on ceramic materials, allows for enhanced visualisation through MRI postoperatively compared to competitive devices, a key imaging modality in spine;
  • Anatomic Disc Heights: The Simplify Disc is anatomically designed and includes 4mm, 5mm, and 6mm options. The 4mm, the lowest disc height in the market,2 more closely matches the native disc height of a wide range of patients; and
  • Physiologic Motion: The proprietary disc design provides unique articulation which allows a variable centre of rotation for each treated level and is designed to closely mimic the motion dynamics of a natural spine segment.

LEAVE A REPLY

Please enter your comment!
Please enter your name here